Monash IVF Group Ltd
Company Profile
Business description
Monash IVF Group Ltd is a provider of fertility services and a driving force in the development of Assisted Reproductive Technologies (ART) and tertiary-level prenatal diagnostics, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates through two main segments: Australia IVF and Ultrasound, which provides Assisted Reproductive Services, Ultrasound and other related services, and other related services. Its business includes KL Fertility, Monash IVF, Monash IVF KPJ Johor, Monash Ultrasound for Women and Repromed, among others. The majority of revenue is generated from the Australia IVF and Ultrasound segment.
Contact
510 Church Street
Level 1
CremorneVIC3121
AUST: +61 394208235
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
Employees
771
Stocks News & Analysis
stocks
Nvidia: Hugging Face acquisition both a wise offensive and defensive move
stocks
Anthropic’s IPO will be huge—and risky. Here are the challenges investors should watch
stocks
Chart of the Week: China demand for copper falls amidst record rally
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,196.00 | 54.60 | -0.59% |
| CAC 40 | 8,278.77 | 7.63 | -0.09% |
| DAX 40 | 26,046.40 | 43.08 | 0.17% |
| Dow JONES (US) | 53,414.25 | 271.86 | -0.51% |
| FTSE 100 | 10,831.09 | 0.43 | -0.00% |
| HKSE | 25,650.87 | 437.56 | 1.74% |
| NASDAQ | 26,506.99 | 77.07 | -0.29% |
| Nikkei 225 | 65,020.94 | 806.46 | 1.26% |
| NZX 50 Index | 13,974.18 | 128.00 | 0.92% |
| S&P 500 | 7,718.60 | 29.11 | -0.38% |
| S&P/ASX 200 | 9,005.90 | 64.30 | -0.71% |
| SSE Composite Index | 3,930.12 | 11.97 | -0.30% |